首页 > 《中华医学杂志（英文版）》 > 2020年21期 > Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer

Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer

在线阅读下载PDF 导出详情

摘要无

DOI wjvqy1o9d7/4907902

作者 Li Wen-Qian Li Ling-Yu Bai Ri-Lan Qian Lei Chen Nai-Fei Cui Jiu-Wei

机构地区 Department of Cancer Center, The First Hospital of Jilin University, Changchun, Jilin 130021, China

出处《中华医学杂志（英文版）》 2020年21期

关键词

分类 [医药卫生][]

出版日期 2020年11月08日（中国期刊网平台首次上网日期，不代表论文的发表时间）

相关文献

1Cheng Ying,Li Hui,Zhang Liang,Liu Jing-Jing,Yang Chang-Liang,Zhang Shuang. Current and future drug combination strategies based on programmed death-1/programmed death-ligand 1 inhibitors in non-small cell lung cancer.医药卫生,2021-08.
2Mari Mino-Kenudson. Programmed cell death ligand-1 （PD-L1） expression by immunohistochemistry： could it be predictive and/or prognostic in non-small cell lung cancer？.肿瘤,2016-02.
3Xu Jia-Li,Wang Xin-Zhu,Jiang Hu-Ning,Chen Yi,Wang Rong,Shu Yong-Qian. Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer.医药卫生,2020-11.
4Jiayi Deng,Ming Gao,Qing Gou,Chongrui Xu,Honghong Yan,Mingyi Yang,Jiakang Li,Xiaorong Yang,Xuewu Wei,Qing Zhou. Organ-specific efficacy in advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors.医药卫生,2022-12.
5Zhou Fei,Zhou Cai-Cun. Immunotherapy in non-small cell lung cancer: advancements and challenges.医药卫生,2021-05.
6Zhao Jing,Huang Jian. Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1.医药卫生,2020-08.
7. Corrigendum: Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1.医药卫生,2021-03.
8Li Chu-Ling,Song Yong. Combination strategies of immunotherapy in non-small cell lung cancer: facts and challenges.医药卫生,2021-09.
9Yu-Sook Jeong;Hye-Suk Han;Sung-Nam Lim;Mi-Jin Kim;Joung-Ho Han;Min-Ho Kang;Dong-Hee Ryu;Ok-Jun Lee;Ki-Hyeong Lee;Seung-Taik Kim. Gallbladder Metastasis of Non-small Cell Lung Cancer Presenting as Acute Cholecystitis.肿瘤,2012-03.
10Siyuan Ren,Mengyao Ma,Chuan He,Yuhui Deng,Xiaoyun Chen,Yonglin Liu,Yangyang Jin,Yansong Liu,Lei Cai,Lin He. Placebo effect in the treatment of non-small cell lung cancer: a meta-analysis.医药卫生,2022-12.

来源期刊

中华医学杂志（英文版）

中华医学杂志（英文版）

相关推荐

同分类资源更多

相关关键词

返回顶部